Citation

Wrobleski ST, Moslin R, Lin S, Zhang Y, Spergel S, Kempson J, Tokarski JS, Strnad J, Zupa-Fernandez A, Cheng L, Shuster D, Gillooly K, Yang X, Heimrich E, McIntyre KW, Chaudhry C, Khan J, Ruzanov M, Tredup J, Mulligan D, Xie D, Sun H, Huang C, D'Arienzo C, Aranibar N, Chiney M, Chimalakonda A, Pitts WJ, Lombardo L, Carter PH, Burke JR, Weinstein DS.: Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165. J Med Chem, Volume 62 (20), 2019

Authors

Aranibar N, Burke JR, Carter PH, Chaudhry C, Cheng L, Chimalakonda A, Chiney M, D'Arienzo C, Gillooly K, Heimrich E, Huang C, Kempson J, Khan J, Lin S, Lombardo L, McIntyre KW, Moslin R, Mulligan D, Pitts WJ, Ruzanov M, Shuster D, Spergel S, Strnad J, Sun H, Tokarski JS, Tredup J, Weinstein DS., Wrobleski ST, Xie D, Yang X, Zhang Y, Zupa-Fernandez A

Journal

J Med Chem

Year

2019

DOI

10.1021/acs.jmedchem.9b00444

PubMed

31318208

Machine-readable

REST APIRDF